Omni MedSci v. Apple reawakens patent troll debate

Apple has recently become involved in a lawsuit that looks set to reawaken the debate around non-practicing entities and the issue of so-called patent trolls. On 6 April 2018 Omni MedSci, Inc. filed a lawsuit in the Eastern District of Texas alleging Apple was infringing four of Omni MedSci’s patents...

Read more

Asking the right questions to optimise life sciences IP

This article was originally published on Biotech and Money. Supporting commercial goals by asking ‘why?’ As there is no one-size-fits-all approach to developing an effective IP strategy, GJE ensures it has a thorough understanding of its clients’ objectives and developments within their businesses so that it is able to offer the...

Read more

Medical imaging- increasing innovation yet outdated equipment

If you are unfortunate enough to require an MRI or CT scan, you might reasonably expect that the equipment is state-of-the-art.  However, a recent report published by AXREM suggests that over half of CT and MRI scanners in the UK are more than five years old, with more than 10%...

Read more

What You Didn’t See at the Super Bowl: What The NFL’s Secret Technology War Can Teach Your Business

The culmination of the NFL’s 2018 season, the Super Bowl, was played last night between the New England Patriots and the Philadelphia Eagles. Those of you who stayed up late would have seen the Eagles crowned NFL champions as they overcame the Patriots 41 – 33 in the game’s dying minutes. However, what...

Read more

Biotech vs Medtech: Differences in Mapping an IP Portfolio

This article was originally published on Biotech and Money as a two-part series. Read part one here. IP portfolio management is often overlooked, but is extremely important if the goal is to protect products or services in the most cost-efficient way possible. However, the process of mapping an IP portfolio to...

Read more